News Center

Clear filters

New E&L Laboratory in Navi Mumbai, India

We’re happy to announce that we will soon open a state-of the-art E&L laboratory in Navi Mumbai, to support global clients in meeting international safety standards.

Enhanced Bioanalytical Testing Capacity Now Available in Poitiers

Find out how our latest state-of-the-art upgrade helps us continue to meet growing demand for our drug development testing services.

SGS Collaborates with ECCRT for Pharmacy Team GMP Training

A renewed collaboration with ECCRT will help ensure the SGS Pharmacy team stays up to date with the latest standards and highest international requirements.

Are Biosimilars Yet to Fulfill Their True Potential?

Luc-Alain Savoy wrote an article "Are Biosimilars Yet to Fulfill Their True Potential?" on LinkedIn.

SGS’s Outstanding Work Recognized by Customers at the CRO Leadership Awards 2021

For the fifth consecutive year, SGS Health Science has been recognized by the exclusive CRO Leadership Awards. In the 2021 awards, SGS was delighted to win three awards for its industry-leading compatibility, reliability and quality across two groups of respondents (Big Pharma and Overall).

SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy

We are providing a full scope of trial services to support a new FIH dose-escalation study evaluating ImmTOR in gene therapy, conducted at the SGS CPU in Antwerp, Belgium.

SGS Nominated for Best Contract Research Organization at the ViE Awards

We have been nominated for ‘Best Contract Research Organization’ at the Vaccine industry Excellence (ViE) Awards.

Increased Capacity for Human Challenge Studies

We're moving our Clinical Pharmacology Unit (CPU) to a new location in 2021, increasing its capacity to conduct human challenge studies.